Clinical Trial Update: Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7 [Phase 3]

View source ↗

Summary

ECZTRA 7, a Phase 3 trial evaluating tralokinumab in combination with topical corticosteroids for severe atopic dermatitis, has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2021-10-26